The only European conference focusing specifically on competition law in the pharma sector.
Get the full picture in just 1 day... enforcement, mergers, Article 102, patents, FDI, FSR, disparagement, distribution challenges, as well as combination therapies and biosimilars - we have you covered!
Regulators, in-house counsel & top legal minds from across the pharma industry sharing their insights:
Your essential 1-day update. Highlights for 2024 include:
Hear from the Regulators
Hear from Anna Vernet, Head of Unit, DG Competition, European Commission on their current priorities for the sector and ask your burning questions during the Q&A.
You will then have an opportunity to hear from representatives from key national competition authorities to ensure you are fully up to date with enforcement across Europe.
Mergers, FDI & FSR
Inspect the current approach to mergers, including where we are with Article 22 after the ECJ judgment in Illumina/ Grail and the use of Article 102 after TowerCast, as well as broader issues relating to innovation and below-threshold deals.
Then gain practical tips on how to manage multijurisdictional transactions in light of merger control, FDI & FSR considerations.
Article 102
Examine where we are with the EC’s update on draft Article 102 guidelines, what the Commission is trying to achieve and an update on recent excessive pricing decisions, exclusionary conduct, and rebates.
Combination Therapies
Discuss combination therapies, their challenges from a competition law perspective, and how the regulators are approaching them. What can the authorities do to facilitate greater entry of combination therapies into the market? Is there a need for a coordinated approach to combination therapies across EU?
Disparagement
Analyse the EC’s recent Vifor and Teva cases, how national regulators are approaching disparagement and what lessons can be learned for corporate compliance including promotional efforts, internal processes and codes of ethics.
Patents
Gain an update on recent EU and national developments including product hopping and 2nd generation products as well as the latest from the Unified Patent Court (UPC).
Connect with the pharma community!
Join us for a drinks reception to catch up with your peers and make new connections in an informal setting.
CompLaw: Pharma in numbers:
0
years as the leading review of competition law in the pharma sector
100+
Attendees
53%
in-house counsel & regulators joining the event
CPD Certification - 6.5 CPD Hours Available
Attendance at this conference may be used to claim CPD from your professional body. The number of hours, or points may vary from body to body. Upon request, we will supply you with a certificate of attendance to facilitate your CPD submission with your professional membership organisation.
Interested in getting involved?
Get in touch with us today to discuss a sponsorship and exhibition package that can help you demonstrate your knowledge and expertise, generate leads and put your brand in the spotlight.
For more information please contact Enes Duzen on Enes.Duzen@informa.com or call +44 (0) 20 8052 0469.